SCHEMBL31436667

SCHEMBL31436667

CCOC(=O)C1(c2cccc(F)c2)C(C)N(C)C1C

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ OPRM1 P35372 5/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ OPRD1 P41143 3/20 0.40
▸ OPRK1 P41145 3/20 0.40
▸ SLC22A1 O15245 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26637741 1.00 LMNA (0.41) LMNAMEN1KMT2AOPRM1ALDH1A1
SCHEMBL31685961 0.84 LMNA (0.45) LMNAMEN1KMT2AOPRM1ALDH1A1
SCHEMBL26637819 0.84 LMNA (0.45) LMNAMEN1KMT2AOPRM1ALDH1A1
SCHEMBL26637720 0.83 OPRM1 (0.41) OPRM1ALDH1A1OPRD1OPRK1SLC22A1
SCHEMBL31436608 0.83 OPRM1 (0.41) OPRM1ALDH1A1OPRD1OPRK1SLC22A1
SCHEMBL26638068 0.78 OPRK1 (0.40) MEN1KMT2AALDH1A1OPRK1SLC6A4
SCHEMBL26638121 0.78 OPRM1 (0.42) MEN1KMT2AOPRM1ALDH1A1OPRD1
SCHEMBL30477031 0.74 LMNA (0.58) LMNAOPRM1ALDH1A1OPRD1OPRK1
SCHEMBL31685947 0.73 SLC6A2 (0.45) LMNAMEN1KMT2AOPRM1ALDH1A1
SCHEMBL26637568 0.73 SLC6A2 (0.45) LMNAMEN1KMT2AOPRM1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119486999-A Azetidine compounds, pharmaceutical compositions thereof, methods of preparation and their use in the treatment of CNS disorders 伊科诺姆有限公司 2025-02-18 — — CN disclosed
Send feedback